← Every company
Pfizer Inc Lobbying
What Pfizer Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
PFE on carbonthat →Disclosed spend
$7.7M
across every filing on file
Filings
25
Years covered
1
Firms retained
4
What it lobbies about
Medicare/MedicaidHealth IssuesTaxation/Internal Revenue CodeLabor Issues/Antitrust/WorkplacePharmacyCopyright/Patent/Trademark
25 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20261st Quarter (Jan 1 - Mar 31) | PFIZER INC.Copyright/Patent/TrademarkHealth Issues | $4.4M |
| 20262nd Quarter (Apr 1 - June 30) | PFIZER INC.Copyright/Patent/TrademarkHealth Issues | $1.9M |
| 20262nd Quarter (Apr 1 - June 30) | MILLER STRATEGIES, LLCMedicare/MedicaidHealth Issues | $150K |
| 20261st Quarter (Jan 1 - Mar 31) | MILLER STRATEGIES, LLCMedicare/MedicaidHealth Issues | $150K |
| 20261st Quarter (Jan 1 - Mar 31) | THE WASHINGTON TAX & PUBLIC POLICY GROUPTaxation/Internal Revenue Code | $110K |
| 20261st Quarter (Jan 1 - Mar 31) | WILLIAMS AND JENSEN, PLLCHealth IssuesTaxation/Internal Revenue Code | $60K |
| 20262nd Quarter (Apr 1 - June 30) | WILLIAMS AND JENSEN, PLLCTrade (domestic/foreign)Budget/Appropriations | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | RESOLUTION PUBLIC AFFAIRS, LLCHealth IssuesMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | BGR GOVERNMENT AFFAIRSHealth Issues | $60K |
| 20262nd Quarter (Apr 1 - June 30) | MARSHALL & POPP, LLCPharmacyCopyright/Patent/Trademark | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | THE DUBERSTEIN GROUP INC.Budget/AppropriationsHealth Issues | $60K |
| 20262nd Quarter (Apr 1 - June 30) | BGR GOVERNMENT AFFAIRSHealth Issues | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | FEDERAL HEALTH POLICY STRATEGIESHealth Issues | $60K |
| 20262nd Quarter (Apr 1 - June 30) | FEDERAL HEALTH POLICY STRATEGIESHealth Issues | $60K |
| 20262nd Quarter (Apr 1 - June 30) | THE DUBERSTEIN GROUP INC.Budget/AppropriationsHealth Issues | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | MARSHALL & POPP, LLCTrade (domestic/foreign)Taxation/Internal Revenue Code | $60K |
| 20262nd Quarter (Apr 1 - June 30) | RESOLUTION PUBLIC AFFAIRS, LLCHealth IssuesMedicare/Medicaid | $60K |
| 20262nd Quarter (Apr 1 - June 30) | TODD STRATEGY GROUPPharmacyTariff (miscellaneous tariff bills) | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | TODD STRATEGY GROUPPharmacyTariff (miscellaneous tariff bills) | $60K |
| 20262nd Quarter (Apr 1 - June 30) | AKIN GUMP STRAUSS HAUER & FELD | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | AKIN GUMP STRAUSS HAUER & FELD | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | BGR GOVERNMENT AFFAIRSHealth Issues | — |
| 20262nd Quarter (Apr 1 - June 30) | THE WASHINGTON TAX & PUBLIC POLICY GROUPTaxation/Internal Revenue Code | — |
| 20261st Quarter (Jan 1 - Mar 31) | ALTRIUS GROUP, LLC | — |
| 20262nd Quarter (Apr 1 - June 30) | ALTRIUS GROUP, LLC | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on PFE
Company overviewEverything on PFE in one place, with the price.SEC filingsWhat PFE's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat PFE's own officers and directors buy and sell.Who owns itEvery manager reporting a position in PFE.Funds holding itWhich funds and ETFs hold PFE, and how big a bet.Who lobbies for itThe lobbyists on PFE's account, and who they worked for.Federal contractsWhat federal agencies pay PFE.PatentsWhat PFE is filing at the patent office.